Clover Health Investments, Corp. Class A Common Stock (CLOV) Stock
Key stats
- Market cap
- $2.66B
- Price / Earnings ratio
- 212.0x
- EPS (TTM)
- $0.01
- Volume
- Loading
- 52-week high
- $5.59
- 52-week low
- $1.58
Source: third-party data provider, as of November 13, 2026
Compare with CLOV
Recent news

HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
CLOV

Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
CLOV

ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
CLOV

CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences
CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences
CLOV
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 59.66
- MACD 12/26/9
- 0.07
- EMA 9 of MACD
- 0.03
- MACD histogram
- 0.04
- SMA 50
- $4.58
- Price above SMA 50
- EMA 50
- $4.58
- Price above EMA 50
- SMA 200
- $3.63
- Price above SMA 200
- EMA 200
- $3.70
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
CLOV

Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
CLOV

ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
ALHC Stock Tumbles After ‘Don’t Poke the Bear’ Silence On Star Ratings — CLOV Falls With It
CLOV

CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences
CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences
CLOV

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
CLOV

Clover Health Investments Q2 Earnings Call Highlights
Clover Health Investments Q2 Earnings Call Highlights
CLOV

Is Clover Health Finally Turning the Corner?
Is Clover Health Finally Turning the Corner?
CLOV

Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
CLOV

Clover Health says employee accounts accessed in cyber incident
Clover Health says employee accounts accessed in cyber incident
CLOV

Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
CLOV
News tone: automated (AI) classification of the article's content, not a price prediction.
About Clover Health Investments, Corp. Class A Common Stock
No description available.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Andrew Toy | Co-Founder, CEO & Director | 1979 |
| Ms. Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | 1969 |
| Mr. Conrad Wai | CEO of Counterpart Health | 1981 |
| Mr. Vivek Garipalli | Co-Founder & Executive Chairman | 1979 |
| Mr. Clay Thornton | Interim Chief Financial Officer | 1990 |
| Mr. Joseph Frank Oldakowski | VP of Finance, Controller & Principal Accounting Officer | 1983 |
| Ms. Wendy Richey | Chief Compliance Officer | — |
| Ms. Karen Soares | Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary | 1978 |
| Ms. Rachel Fish | Chief People Officer | — |
| Dr. Kumar Dharmarajan | Chief Medical Officer of Clover Assistant | 1980 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 59.66
- MACD 12/26/9
- 0.07
- EMA 9 of MACD
- 0.03
- MACD histogram
- 0.04
- SMA 50
- $4.58
- Price above SMA 50
- EMA 50
- $4.58
- Price above EMA 50
- SMA 200
- $3.63
- Price above SMA 200
- EMA 200
- $3.70
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $5.50
- Average
- $5.75
- High
- $6.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -34.4 | -16.8 | ||||||||||
| 2022 | -36.3 | -2.5 | +31.0 | -23.8 | -5.3 | -12.3 | +24.4 | -10.6 | -32.0 | -10.2 | -17.6 | -30.1 |
| 2023 | +40.0 | -1.5 | -24.8 | -12.9 | +9.0 | +5.9 | +43.7 | +0.8 | -18.8 | -12.0 | +1.1 | +0.0 |
| 2024 | +0.0 | -14.0 | -9.2 | -18.2 | +71.9 | +5.1 | +59.2 | +46.1 | +12.8 | +48.2 | -17.1 | -8.2 |
| 2025 | +40.3 | -7.9 | -1.4 | -5.3 | -5.4 | -12.0 | +5.1 | -5.8 | +13.8 | +34.7 | -32.3 | -6.0 |
| 2026 | -7.1 | -5.0 | -13.7 | +61.8 | +46.9 | +33.7 | -22.6 | -4.2 | +0.2 | +5.4 | +15.3 |



